Page 2 - ப்ராஜெக்ட் லேல News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article
Provides Clinical Development Update on 18-MC
Based on positive pre-IND meeting with U.S. Food and Drug Administration (FDA), MindMed is now prepared to open an Investigational New Drug (IND) in August 2021 with a Phase 2b clinical trial for LSD assisted therapy in anxiety
MindMed continues dose escalation of 18-MC in Phase I SAD/MAD; Meeting confirmed with FDA
NEW YORK, Dec. 14, 2020 /PRNewswire/  MindMed (NEO: MMED,OTCQB: MMEDF, DE: MMQ), a leading psychedelic medicine biotech company today announced the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of lysergic acid diethylamide (LSD) assisted therapy for an anxiety disorder. ....

United States , Judy Ashworth , Mindmed Co , Clinical Development , Medicine Mindmed Inc , Mindmed Co Founder , Project Lucy , Project Layla , Ascending Dose , Single Ascending Dose , Serious Adverse Events , Mind Medicine , ஒன்றுபட்டது மாநிலங்களில் , ஜூடி ஆஷ்வொர்த் , மருத்துவ வளர்ச்சி , ப்ராஜெக்ட் லூசி , ப்ராஜெக்ட் லேல , ஏறுதல் டோஸ் , ஒற்றை ஏறுதல் டோஸ் , மனம் மருந்து ,